Beautiful Space is dedicated to the ethical advancement of holistic mental healthcare, utilising plant-based medicines and legal psychedelic-assisted relationship therapy for individuals and couples.

Psychedelics Design is a pioneering platform at the intersection of psychedelics and design, exploring how these two fields can synergize to create more sustainable and regenerative futures.

The PsychedeliCare Initiative is the first European Citizens' Initiative dedicated to raise awareness about the benefits of psychedelic-assisted therapies (PATs) for mental health in the EU. Through a year-long European campaign, the initiative aims to collect one million signatures to formally call on the European Commission to ensure equitable, timely, affordable, safe, and legal access to PATs in the EU.

Bridging the gap between fungal wisdom and modern understandings of wellness, our service allows you to incorporate functional mushrooms and natural remedies into your life in the way that works best for you. Whether you're new to functional mushrooms or looking to enhance your health routine, a personalised one-on-one consultation will provide tailored advice to suit your specific needs.

Shortwave Life Sciences is a biopharmaceutical company developing novel drug combinations and delivery methods to treat patients suffering from life-threatening mental health disorders. We identify, operate and create value from early-stage, breakthrough initiatives, with an initial focus on eating disorders and anorexia nervosa.

Heroic Hearts Project UK (HHPUK) helps UK military and emergency services veterans gain legal access to psychedelic therapy.

PsyEdu is one of the UK's leading Psychedelic Educational organisations, and it is our vision to be the national centre of excellence.

Onaya is an organisation that focuses on providing comprehensive support for those involved in psychedelic experiences, particularly in the realms of preparation and integration.

PsyAware is a not-for-profit organisation providing essential education and support systems in the psychedelic space. Our goal is to empower individuals and communities to enhance our collective wellbeing through better understanding and responsible psychedelic practices.

The Imperial Centre for Psychedelic Research and the CIPPRes Clinic are leading psychedelic research in the United Kingdom, building on over a decade of pioneering work in this area carried out at Imperial College London, including a clinical trial that has kick-started global efforts to develop psilocybin therapy into a licensed treatment for depression.

With industry regulations and practices being written alongside its growth, the experience of our advisors can help foresee and navigate the challenges and opportunities of this powerful work.